| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,550 |
8,176 |
$110K |
| 96161 |
|
6,203 |
6,089 |
$43K |
| 96156 |
|
6,317 |
6,268 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,408 |
5,008 |
$32K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,690 |
2,616 |
$19K |
| 92552 |
|
7,511 |
7,365 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,343 |
3,281 |
$16K |
| 96160 |
|
3,168 |
3,105 |
$14K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,302 |
7,127 |
$13K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,269 |
2,234 |
$9K |
| 96127 |
|
7,728 |
7,606 |
$9K |
| 90670 |
|
1,084 |
1,037 |
$9K |
| 99188 |
|
942 |
938 |
$8K |
| G9920 |
Screening performed and negative |
5,829 |
5,780 |
$8K |
| 90686 |
|
3,115 |
3,082 |
$8K |
| 90651 |
|
1,311 |
1,288 |
$8K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,502 |
2,473 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,576 |
1,433 |
$5K |
| 90698 |
|
621 |
591 |
$5K |
| 90716 |
|
358 |
328 |
$4K |
| 99173 |
|
7,042 |
6,929 |
$4K |
| 90461 |
|
2,728 |
2,653 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
875 |
849 |
$4K |
| 90680 |
|
329 |
310 |
$4K |
| 90707 |
|
386 |
356 |
$3K |
| 90734 |
|
513 |
500 |
$2K |
| 90633 |
|
580 |
562 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
820 |
809 |
$2K |
| G9919 |
Screening performed and positive and provision of recommendations |
766 |
754 |
$2K |
| 90744 |
|
339 |
308 |
$2K |
| 99383 |
|
63 |
55 |
$2K |
| 90619 |
|
243 |
243 |
$2K |
| 90671 |
|
107 |
106 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
258 |
218 |
$1K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
774 |
761 |
$1K |
| 90656 |
|
14 |
14 |
$1K |
| 90700 |
|
204 |
188 |
$1K |
| 90715 |
|
347 |
335 |
$1K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
881 |
867 |
$1K |
| 99000 |
|
746 |
732 |
$1K |
| 4004F |
|
2,438 |
2,414 |
$1K |
| 90620 |
|
210 |
207 |
$929.99 |
| 90713 |
|
129 |
120 |
$897.61 |
| 90685 |
|
158 |
132 |
$594.26 |
| 36416 |
|
382 |
378 |
$448.25 |
| 99382 |
|
18 |
16 |
$424.60 |
| 83655 |
|
243 |
239 |
$393.78 |
| 85018 |
|
424 |
415 |
$388.55 |
| 94760 |
|
236 |
199 |
$382.11 |
| 90648 |
|
89 |
82 |
$331.76 |
| 86580 |
|
238 |
220 |
$322.92 |
| 90696 |
|
81 |
77 |
$305.91 |
| 90697 |
|
196 |
196 |
$195.00 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
96 |
89 |
$120.00 |
| 87081 |
|
92 |
90 |
$106.78 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
254 |
214 |
$14.03 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
643 |
606 |
$0.00 |
| 81002 |
|
12 |
12 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
514 |
509 |
$0.00 |
| 99401 |
|
26 |
26 |
$0.00 |
| 90710 |
|
25 |
25 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
177 |
175 |
$0.00 |
| 97803 |
|
12 |
12 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20 |
19 |
$0.00 |
| 0071A |
|
24 |
24 |
$0.00 |
| 0001A |
|
35 |
35 |
$0.00 |
| 96150 |
|
147 |
147 |
$0.00 |
| 0072A |
|
41 |
41 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
313 |
304 |
$0.00 |